Key facts
- This page summarizes David Jin's Form 4 filing for Fortress Biotech, Inc. (FBIO).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 12 Jul 2024, 08:42.
David Jin - 10 Jul 2024 Form 4 Insider Report for Fortress Biotech, Inc. (FBIO)
- Reporting relationship
- Chief Financial Officer
- Issuer ticker
- FBIO
- Reported as of
- 10 Jul 2024
- Net transaction value
- +$3,750
- SEC form
- 4
- Accepted by SEC
- 12 Jul 2024, 08:42:21 UTC
- Prior SEC filing
- 02 Apr 2024
- Next SEC filing
- 25 Sep 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ David Jin
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
David Jin filed Form 4 for Fortress Biotech, Inc. (FBIO) on 12 Jul 2024.
Change
- Previous filing in this sequence was filed on 02 Apr 2024.
- Current net transaction value: +$3,750.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
FBIO
transaction
SERIES A CUMULATIVE PERPETUAL PREFERRED STOCK
Purchase
- Transaction value
- $3,750
- Shares
- +500
- Change %
- Price
- $7.50*
- Shares after
- 500
- Date
- 10 Jul 2024
- Ownership
- Direct
* marks a reported price that did not pass the local price check.